ArticleClinical ophthalmology (Auckland, N.Z.)2025

Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study.

Somnath Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.